ASCO 2014: A phase Ib dose escalation trial of SAR650984 in combination with len/dex in RR MM

Thomas G. Martin, MD University of California SF San Francisco, California, USA A phase Ib dose escalation trial of SAR650984 (Anti-CD-38 mAb) in combination with lenalidomide and dexamethasone i... Author: InternationalMyelomaFoundation Added: 09/10/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts